# Clinical Trial of SAHA in Patients With Breast Cancer

> **NCT00416130** · PHASE1,PHASE2 · UNKNOWN · sponsor: **National University Hospital, Singapore** · enrollment: 49 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Vorinostat

## Key facts

- **NCT ID:** NCT00416130
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-01
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2013-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00416130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00416130, "Clinical Trial of SAHA in Patients With Breast Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00416130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*